Stellate’s origins are in the ground-breaking research conducted by Dr. Jean Gotman at the world-renowned Montreal Neurological Institute in the field of computerized EEG analysis. The company’s spike and seizure detectors, a product of this research, quickly became the industry standard. Throughout its evolution, Stellate has maintained its high focus on R&D as a route to continuous product innovation. Today, Stellate is actively involved in several ongoing research programs in the development of new methods of analysis in the fields of Epilepsy, Polysomnography and Neurodiagnostic monitoring in the Intensive Care Unit.

The company maintains a vibrant Research & Development department manned by highly qualified PhDs. Active collaboration with universities and hospitals brings together the knowledge, skills and expertise of health care professionals, scientists, software developers and engineers around the world and provides access to a wide body of knowledge. Numerous published papers in leading scientific journals attest to the high standards that the R&D team follows in product development and validation.

Current R&D programs are focused on state-of-the-art technology and new methods of data management and analysis designed to increase power and versatility, simplify workflows and enhance efficiency. These will result in products that will continue to add unique value and help deliver better patient care.